About Evaluate
Evaluate is a company based in London (United Kingdom) founded in 1996 was acquired by HgCapital Trust in August 2020. It operates as a Data-as-a-Service and Professional Services. Evaluate has completed 5 acquisitions, including BiosciDB, Bioscience Advisors and Black Swan Analysis. Evaluate offers products and services including Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform. Evaluate operates in a competitive market with competitors including Curatio healthcare, Science and Medicine Group, Kineticos, Cello Health Advantage and J+D Forecasting, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Evaluate, A Norstella Company
-
Annual Revenue
$89.89 K (USD)-2as on Dec 31, 2022
-
Net Profit
$16.54 K (USD)-25as on Dec 31, 2022
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
BiosciDB
& 4 more
-
Acquired by
HgCapital Trust
(Aug 04, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evaluate
Evaluate offers a comprehensive portfolio of products and services, including Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform.
Data and insights for pharmaceutical market analysis are provided.
Comprehensive market data for drug development is offered here.
Tools for market sizing and forecasting are made available.
People of Evaluate
Unlock access to complete
Funding Insights of Evaluate
Investors in Evaluate
Evaluate has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include HgT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are focused on European software firms.
|
Locked | Locked | Locked |
Investor details for Evaluate
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evaluate
Evaluate has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include BiosciDB, Bioscience Advisors and Black Swan Analysis.
Investment portfolio details for Evaluate
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cloud-based database management software is offered for healthcare professionals.
|
Locked | Locked | 2012 | Locked | |
|
Consulting services for the biopharma sector are provided.
|
Locked | Locked | 2011 | Locked | |
|
Provider of market analysis & access, data analytics, and consulting services for pharmaceutical sector
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Evaluate
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Evaluate
Detailed financials for Evaluate
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evaluate Comparisons
Peer comparison for Evaluate
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evaluate
Evaluate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curatio healthcare, Science and Medicine Group, Kineticos, Cello Health Advantage and J+D Forecasting, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Market research services for biopharma sector are provided.
|
|
| Locked | Locked | Locked |
Research and advisory services are provided to life-science companies.
|
|
| Locked | Locked | Locked |
Invests in early-stage life sciences companies for innovation, expertise, and growth.
|
|
| Locked | Locked | Locked |
Provider of health care data analytics services
|
|
| Locked | Locked | Locked |
Pharmaceutical forecasting services are provided for global and local markets.
|
Detailed competitors of Evaluate
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evaluate
Complete news archive for Evaluate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evaluate
Evaluate was founded in 1996 and raised its 1st funding round 20 years after it was founded.
Evaluate is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Annual revenue of Evaluate is $89.89K as on Dec 31, 2022.
Evaluate is engaged in delivering comprehensive pharmaceutical market intelligence and forecasting solutions. Services are focused on supporting biotech and pharma companies with data-driven insights for drug development, market competition, and portfolio optimization. Sectors covered include biopharma and medtech, with solutions encompassing competitive intelligence, business development, licensing, and custom analytics. A wide range of tools and consulting services are offered to help clients navigate market complexities and make informed strategic decisions.
Evaluate's top competitors include Curatio healthcare, Cello Health Advantage and Rubix LS.
Evaluate offers Evaluate Pharma, Evaluate Omnium, and Pharma Forecasting Platform.
Evaluate has made 5 acquisitions, including BiosciDB, Bioscience Advisors, and Black Swan Analysis.
Evaluate has 1 investor. Key investors include HgT.